Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Mercado Continuo Espanol  >  FAES Farma SA    FAE   ES0134950F36

FAES FARMA SA (FAE)

6
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mercado Continuo Espanol
06/30/2015 07/01/2015 07/02/2015 07/03/2015 07/06/2015 Date
2.315(c) 2.4(c) 2.325(c) 2.305(c) 2.275(c) Last
176 461 368 132 159 746 131 445 260 194 Volume
+1.31% +3.67% -3.12% -0.86% -1.30% Change
More quotes
Financials (€)
Sales 2015 203 M
EBIT 2015 38,8 M
Net income 2015 27,7 M
Finance 2015 18,0 M
Yield 2015 2,67%
Sales 2016 214 M
EBIT 2016 44,4 M
Net income 2016 32,3 M
Finance 2016 37,1 M
Yield 2016 3,18%
PER 2015 19,65
PER 2016 16,72
EV / Sales 2015 2,69x
EV / Sales 2016 2,46x
Capitalization 564 M
More Financials
Company
Faes Farma SA engages in the manufacture, marketing, and research of pharmaceutical products and raw materials for pharmaceutical use. Its products are for allergies, antihypertensive, dermatological, diabetes, digestive, otorhinolaryngology, osteoarticular, respiratory, women's health, central... 
Sector
Pharmaceuticals
Calendar
07/31Earnings Release
More about the company
Surperformance© ratings of FAES Farma SA
Trading Rating : Investor Rating :
More Ratings
Latest news on FAES FARMA SA
07/01 FAES FARMA SA : ex-dividend day for final dividend
05/18 FAES FARMA : Statement 05/18/2015 (39 k.). Faes Farma has licensed a pharmaceuti..
05/06 FAES FARMA : Comunicado 05/01/2015 (59 k.). Dividendo flexible. Datos de cierre ..
03/02 FAES FARMA : Statement 02/27/2015 (81 k.). Faes Farma increases its net probit b..
2014 FAES FARMA : Statement 05/14/2014 (112 k.). Bilastine in Canada: signing of a li..
2014 FAES FARMA : Statement 05/14/2014 (112 k.). Bilastine in Canada: signing of a li..
2013 FAES FARMA SA : Statement 07/24/2013 (24 k.). January-June results.
2012 FAES FARMA SA : Statement 13/12/2012 (20 k). Faes Farma licences bilastine for S..
More news
Sector news : Pharmaceuticals - NEC
07:06a MALLINCKRODT : To Report Third Quarter Fiscal 2015 Results On August 4, 2015
07:01a MERCK : Allergan Enters Into Licensing Agreement with Merck to Obtain Exclusive ..
07:00a HORIZON PHARMA : Proposes to Acquire Depomed, Inc. for $29.25 per Share in an Al..
More sector news : Pharmaceuticals - NEC


Comments 
Advertisement
Chart FAES FARMA SA
Duration : Period :
FAES Farma SA Technical Analysis Chart | FAE | ES0134950F36 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions